Clinical Features	Time to Death		AGE		PRIMARY.SITE.OF.DISEASE		GENDER		LYMPH.NODE.METASTASIS		TUMOR.STAGECODE		NEOPLASM.DISEASESTAGE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Chi-square test_P	Chi-square test_Q	t-test_P	t-test_Q	Chi-square test_P	Chi-square test_Q
BRAF	16 (70%)	7	0.5469	1	0.44739	1	0.35178	1	0.62584	1	0.30176	1	NA	NA	0.6807	1
NRAS	3 (13%)	20	NA	NA	NA	NA	0.45285	1	1	1	NA	NA	NA	NA	NA	NA
PRB2	4 (17%)	19	NA	NA	0.36812	1	1	1	0.55731	1	0.34333	1	NA	NA	0.1559	1
FAM135B	6 (26%)	17	0.72195	1	0.0041488	0.311	1	1	0.62139	1	0.69697	1	NA	NA	0.46876	1
PTEN	4 (17%)	19	0.082755	1	0.69645	1	0.12456	1	1	1	0.34333	1	NA	NA	0.96113	1
TLL1	6 (26%)	17	0.082755	1	0.073579	1	1	1	1	1	0.30176	1	NA	NA	0.46876	1
ARID2	4 (17%)	19	0.082755	1	0.37045	1	1	1	0.27273	1	0.34333	1	NA	NA	0.96113	1
ZFHX4	8 (35%)	15	0.5469	1	0.73398	1	0.77866	1	0.34522	1	0.40399	1	NA	NA	0.14758	1
CFHR1	5 (22%)	18	0.40377	1	0.3016	1	1	1	0.2719	1	0.95942	1	NA	NA	0.29017	1
OR52M1	3 (13%)	20	NA	NA	0.31897	1	1	1	1	1	0.80428	1	NA	NA	0.33851	1
PPP6C	3 (13%)	20	NA	NA	NA	NA	0.45285	1	1	1	NA	NA	NA	NA	NA	NA
RUNDC3B	3 (13%)	20	0.32187	1	0.15422	1	0.45285	1	0.52569	1	0.19134	1	NA	NA	NA	NA
ADCYAP1R1	3 (13%)	20	0.014306	1	0.22359	1	1	1	1	1	0.83912	1	NA	NA	0.92793	1
KCNC2	3 (13%)	20	NA	NA	NA	NA	0.45285	1	0.20949	1	NA	NA	NA	NA	NA	NA
PIK3R1	4 (17%)	19	0.91286	1	0.75407	1	1	1	0.55731	1	0.081109	1	NA	NA	0.50519	1